Salivary Acetylcholinesterase Activity Is Increased in Parkinson’s Disease: A Potential Marker of Parasympathetic Dysfunction
Introduction. Decreased salivary flow and xerostomia are frequent findings in Parkinson’s disease (PD), possibly caused by alterations in the parasympathetic tonus. Here we explore salivary acetylcholinesterase (AChE) activity as a potential biomarker in PD. Methods. We measured salivary flow, AChE...
Saved in:
Main Authors: | Tatyana Fedorova, Cindy Soendersoe Knudsen, Kim Mouridsen, Ebba Nexo, Per Borghammer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Parkinson's Disease |
Online Access: | http://dx.doi.org/10.1155/2015/156479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skin Temperature in Parkinson’s Disease Measured by Infrared Thermography
by: Mathias Møller Purup, et al.
Published: (2020-01-01) -
Sensory Behaviours and Resting Parasympathetic Functions among Children with and without ADHD
by: Ivan Neil Gomez, et al.
Published: (2021-01-01) -
Isolation of Pleurotus florida derived acetylcholinesterase inhibitor for the treatment of cognitive dysfunction in mice
by: Kudrat Randhawa, et al.
Published: (2021-07-01) -
Salivary Biomarkers: Noninvasive Ways for Diagnosis of Parkinson’s Disease
by: Sanaz Salaramoli, et al.
Published: (2023-01-01) -
Mitochondrial Dysfunction in Parkinson's Disease
by: P. C. Keane, et al.
Published: (2011-01-01)